Sponsor

Ceska Myelomova Skupina z.s.

Czechia Jihlavska 340/20, Bohunice, 625 00 Brno, Czechia

About the sponsor

The sponsor supports clinical research in newly diagnosed multiple myeloma among younger adults eligible for autologous stem cell transplantation, with interest in treatment strategies spanning induction, consolidation, and maintenance care.

Autologous stem cell transplantation
Induction therapy
Consolidation therapy
Maintenance treatment

These studies reflect a focus on sequencing therapies for plasma cell malignancies in transplant-eligible populations.

About Specializations

Ceska Myelomova Skupina z.s. runs clinical trials in conditions such as Plasma cell myeloma refractory, Plasma cell myeloma, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

2 clinical trials

Plasma cell myeloma refractory

Not recruiting

Study of belantamab mafodotin, bortezomib and dexamethasone combination in adults with relapsed or refractory multiple myeloma who received at least one prior therapy

Registered drugNo placebo